Dr Yue Huang | Head of Clinical Pharmacology China

Dr Yue Huang, Head of Clinical Pharmacology China, Merck

Dr. Yue Huang graduated from Beijing Medical University, China, then obtained his PhD from University of Minnesota, USA.  He also completed an executive MBA from Swiss Business School (SBS) in Switzerland. Dr. Huang has 17+ years of pharmaceutical industry experience, with specialties in the clinical pharmacology and exploratory R&D. His career has taken on a path spanning multiple industry settings and geographic locations, including Quintiles (Kansas City, Missouri), Roche (Palo Alto, California), Genentech (South San Francisco, California), and Novartis (Basel, Switzerland). Dr. Huang has worked in numerous pharmaceutical pipeline projects encompassing both small NME and novel biologic large molecules.  Since early 2015, he joined Merck Serono Beijing R&D Hub as the Head of Clinical Pharmacology in Global Early Development China.


EAC 2017 Day 1, Tuesday 31st October 2017 @ 15:10

Biologics development in fast-evolving Chinese market – an industry perspective

  • Biologics represent increasing share of the R&D pipeline for Chinese domestic and MNC pharma
  • Innovative modalities and MOA are gaining attention from local investment
  • Fast-evolving regulatory landscape and R&D infrastructure facilitate NBE and Biosimilar advancement

back to speakers